Blindness
Title: Blindness Category: Diseases and Conditions Created: 3/10/2010 3:30:00 PM Last Editorial Review: 3/10/2010 3:30:02 PM Wed, 10 Mar 2010 00:00:00 PDT
Deep Vein Thrombosis (DVT)
Title: Deep Vein Thrombosis (DVT) Category: Diseases and Conditions Created: 2/15/2000 10:55:00 PM Last Editorial Review: 3/10/2010 Wed, 10 Mar 2010 00:00:00 PDT
Bleeding Alert Sounded for Stroke Drugs
Title: Bleeding Alert Sounded for Stroke Drugs Category: Health News Created: 3/8/2010 4:10:00 PM Last Editorial Review: 3/9/2010 Tue, 9 Mar 2010 00:00:00 PDT
Stroke Risk Runs in the Family
Title: Stroke Risk Runs in the Family Category: Health News Created: 3/8/2010 4:10:00 PM Last Editorial Review: 3/9/2010 Tue, 9 Mar 2010 00:00:00 PDT
Processed Meat May Harm the Heart
Title: Processed Meat May Harm the Heart Category: Health News Created: 3/5/2010 8:10:00 PM Last Editorial Review: 3/8/2010 Mon, 8 Mar 2010 00:00:00 PDT
Medical New Today:
Cardiovascular / Cardiology News
Heart Disease And Stroke Survivors Urge Congress To Increase Funding For The National Institutes Of Health
Enhance National Institutes of Health (NIH)-supported research to improve health, spur economic growth and innovation and science. American Heart Association patient advocates and researchers today delivered that message to members of Congress during the association's Research Saves Lives Fly-In Lobby Day... Thu, 11 Mar 2010 14:00:00 PST
ERT Launches 'Centralized Cardiac Safety 2.0': A Revolutionary New Approach To ECG Management In Clinical Trials
ERT (Nasdaq: ERES), a leading provider of centralized services to the biopharmaceutical, medical device and related industries, announced the launch of Centralized Cardiac Safety 2.0, a portfolio of new solutions that enable a significant new approach to cardiac safety in clinical trials. These new solutions overcome many of the perceived barriers to centralizing all ECGs in clinical trials... Thu, 11 Mar 2010 03:00:00 PST
Research Points To Way To Improve Heart Treatment
Current drugs used to treat heart failure and arrhythmias (irregular heartbeat) have limited effectiveness and have side effects. New basic science findings from a University of Iowa study suggest a way that treatments could potentially be refined so that they work better and target only key heart-related mechanisms... Thu, 11 Mar 2010 03:00:00 PST
New Methods Needed To ID Cardiac Catheterization Candidates
It's time to re-think how patients are selected for cardiac catheterization, say doctors at Duke University Medical Center, after reporting in a new study that the invasive procedure found no significant coronary artery disease in nearly 60 percent of chest pain patients with no prior heart disease... Thu, 11 Mar 2010 03:00:00 PST
Ischemix Initiates Phase 2a Trial Of CMX-2043 For The Prevention Of Ischemia-Reperfusion Injury
Ischemix announced the initiation of patient accrual in a multi-center Phase 2a clinical trial of CMX-2043 for the prevention of peri-operative ischemia-reperfusion injury in patients undergoing elective percutaneous coronary intervention (PCI) procedures... Thu, 11 Mar 2010 00:00:00 PST
HealthHelp Enhances Diagnostic Cardiology Services
HealthHelp, a leading specialty benefit management provider, continues to target health care cost drivers by adding diagnostic cardiac catheterization to its well-established and effective suite of services... Wed, 10 Mar 2010 21:00:00 PST
Racial Disparities Persist In Hospice Use
Even as medical caregivers try to change practices, racial disparities in hospice care continue, according to a study in the March 8 issue of the Archives of Internal Medicine... Wed, 10 Mar 2010 03:00:00 PST
Scivanta Medical Corporation Announces Results For Initial Clinical Trial For The Scivanta Cardiac Monitoring System
Scivanta Medical Corporation (OTC Bulletin Board: SCVM), announced that the results of its initial clinical trial for the Scivanta Cardiac Monitoring System (SCMS) clearly indicate that the SCMS can accurately measure cardiac performance as expected by the company. This clinical trial was performed at Kaleida Health/Millard Fillmore Hospital in Buffalo, New York... Wed, 10 Mar 2010 01:00:00 PST
BG Medicine And Abbott To Develop Galectin-3 Test For The I-STAT(R) System
BG Medicine, Inc. announced that it has entered into an agreement with Abbott Laboratories (NYSE: ABT) to extend its current development and commercialization collaboration to include the development of a galectin-3 test for Abbott Point of Care's i-STAT® System. Galectin-3 is a novel biomarker that may play a role in detecting the development and progression of heart failure... Tue, 09 Mar 2010 15:00:00 PST
How To Avoid Heart Attacks (Blubert Tavedorn)
Heart attack, which is also known as myocardial infarction, is a major cause of worldwide deaths. Heart disease occurs when the arteries that supply oxygenated blood to the heart get blocked due to some stupid clot formation. This blood flow interruption can lead to the damage of the heart muscle and ultimately result in tissue death. Fri, 01 Jan 2010 18:06:29 +0000
Coronary Artery Disease - What You Need to Know (Blubert Tavedorn)
Coronary Artery Disease is commonly known as Heart Disease or Atherosclerosis. In coronary artery disease, plaque builds up inside the arteries. These plaques are formed by fats and cause the arteries to harden. The deposits are made of fat that came from the food that we eat. These fat deposits narrow the arteries and impede circulation. The narrowing of the arteries also... Tue, 04 Aug 2009 19:47:44 +0000
Women and Heart Disease (Eric Jack)
Most people know heart disease is the number one killer in the United States among men, but few realize it is the main killer of women as well. Thu, 02 Jul 2009 11:13:05 +0000
Heart Disease And Stroke Survivors Urge Congress To Increase Funding For The National Institutes Of Health
Enhance National Institutes of Health (NIH)-supported research to improve health, spur economic growth and innovation and science. American Heart Association patient advocates and researchers today delivered that message to members of Congress during the association's Research Saves Lives Fly-In Lobby Day... Thu, 11 Mar 2010 14:00:00 PST
Research Points To Way To Improve Heart Treatment
Current drugs used to treat heart failure and arrhythmias (irregular heartbeat) have limited effectiveness and have side effects. New basic science findings from a University of Iowa study suggest a way that treatments could potentially be refined so that they work better and target only key heart-related mechanisms... Thu, 11 Mar 2010 03:00:00 PST
New Methods Needed To ID Cardiac Catheterization Candidates
It's time to re-think how patients are selected for cardiac catheterization, say doctors at Duke University Medical Center, after reporting in a new study that the invasive procedure found no significant coronary artery disease in nearly 60 percent of chest pain patients with no prior heart disease... Thu, 11 Mar 2010 03:00:00 PST
Ischemix Initiates Phase 2a Trial Of CMX-2043 For The Prevention Of Ischemia-Reperfusion Injury
Ischemix announced the initiation of patient accrual in a multi-center Phase 2a clinical trial of CMX-2043 for the prevention of peri-operative ischemia-reperfusion injury in patients undergoing elective percutaneous coronary intervention (PCI) procedures... Thu, 11 Mar 2010 00:00:00 PST
HealthHelp Enhances Diagnostic Cardiology Services
HealthHelp, a leading specialty benefit management provider, continues to target health care cost drivers by adding diagnostic cardiac catheterization to its well-established and effective suite of services... Wed, 10 Mar 2010 21:00:00 PST
BG Medicine And Abbott To Develop Galectin-3 Test For The I-STAT(R) System
BG Medicine, Inc. announced that it has entered into an agreement with Abbott Laboratories (NYSE: ABT) to extend its current development and commercialization collaboration to include the development of a galectin-3 test for Abbott Point of Care's i-STAT® System. Galectin-3 is a novel biomarker that may play a role in detecting the development and progression of heart failure... Tue, 09 Mar 2010 15:00:00 PST
ECG Screening Of Hyperactive Children Borderline Cost-effective
Evaluating children for underlying heart problems before prescribing stimulant medications can identify children at risk for sudden cardiac death, but electrocardiogram (ECG) screening is of borderline cost-effectiveness compared to current practice, according to research reported in Circulation: Journal of the American Heart Association... Tue, 09 Mar 2010 09:00:00 PST
Medicine To Lower Blood Pressure Significantly Decreases Risk For Cardiovascular Disease, Stroke
A long-acting ACE inhibitor used to reduce blood pressure significantly decreased the risk for cardiovascular disease, including stroke, in normal weight, overweight and obese patients, according to research reported in Hypertension: Journal of the American Heart Association... Tue, 09 Mar 2010 08:00:00 PST
Disclaimer
All content within ooBdoo Health and Medical categories is provided for
general information only, and should not be treated as a substitute
for the medical advice of your own doctor or any other health care professional.
ooBdoo is not responsible or liable for any diagnosis made by
a user based on the content of the ooBdoo website. ooBdoo is not liable
for the contents of any external internet sites listed, nor does it endorse
any commercial product or service mentioned or advised on any of the sites.
Always consult your own doctor if you're in any way concerned
about your health.
